首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section
【24h】

A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section

机译:常规剂量催产素和80单位剂量催产素预防剖宫产产后出血的比较研究

获取原文
           

摘要

Postpartum hemorrhage is one of the main causes of mothers' death mostly in developing country. The frequency of postpartum hemorrhage after natural pregnancy and cesarean are reported 2%–4% and 6%, respectively. The main goal of this study is to compare two regimens of oxytocine: One with high dose and the other with normal one to prevent uterine atony. The study has been done via a clinical trial method on 150 pregnant women in Zahedan, Iran. The society is randomly divided into two groups. The patients having risk factors of uterine atony and postpartum hemorrhage were omitted from the list. Oxytocin with 80 and 30 dose was, respectively, infused in 500 cc Ringer serum for control and witness group immediately after infant emersion during a period of 30 min. Decline of hemoglobin 6 and 24 h after cesarean section, uterine atony, blood infusion, and extra uterotonic drug needs after oxytocin infusion have been measured for both groups. The data have been analyzed using Chi-square via SPSS software. The result indicates that there exist meaningful differences between control and witness group in uterine atony and extra utertonic drug need while and after surgery (0 as compared with 22.6% and P= 0); whereas there is no significant difference between control and trial group in decline of hemoglobin 6 and 24 h after cesarean section (P = 0.714 and 0.231, respectively). It means that oxytocin infusion with 80 dose has a good impact on the above four variances. It is recommended that oxytocin infusion with 80 dose during a period of 30 min could be a good substitution for oxytocin infusion with 30 dose for the prevention of uterine atony during and after cesarean delivery, especially when utertonic drug is not accessible and in the case of counterindication of other drugs' use.
机译:产后出血是母亲死亡的主要原因之一,主要在发展中国家。自然妊娠和剖宫产后产后出血的频率分别报告为2%–4%和6%。这项研究的主要目的是比较两种催产素的方案:一种高剂量,另一种正常,以预防子宫收缩乏力。该研究已通过临床试验方法在伊朗Zahedan的150名孕妇中进行。社会被随机分为两组。清单中省略了具有子宫收缩乏力和产后出血危险因素的患者。婴儿出现后立即在30分钟内分别将500和80剂量的催产素注入500 cc林格氏液中作为对照组和见证组。剖宫产后6小时和24小时血红蛋白下降,子宫无力,输血和催产素输注后子宫内缩宫药的需求量均已测量。数据已通过SPSS软件使用卡方分析。结果表明,对照组和证人组之间在子宫收缩乏力和术前和术后子宫外药物需求方面存在有意义的差异(0比22.6%,P = 0);剖宫产术后6小时和24小时血红蛋白下降与对照组和试验组之间无显着差异(分别为P = 0.714和0.231)。这意味着80剂量的催产素输注对上述四个变化有良好的影响。建议在30分钟内输注80剂量的催产素可以很好地替代30剂量的催产素,以防止剖宫产过程中和剖宫产后子宫收缩乏力,尤其是在无法使用子宫药物且发生剖宫产的情况下。禁止其他药物的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号